Carel Le Roux

Professor

University College Dublin College of Health Sciences

Ireland

Research Interests

Explore related searches

Professors in Ireland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Werd Al-Najim

Dublin City University

IRELAND

View details

ALEX MIRAS

University of Ulster

UNITED KINGDOM

View details

Gary A Wittert

AUSTRALIA

View details

John Wilding

Professor of Medicine

University of Liverpool

UNITED KINGDOM

View details

John McEvoy

Professor of Preventive Cardiology

IRELAND

View details

Georgios K. Dimitriadis

King’s College London

UNITED KINGDOM

View details

Lina Zgaga

Associate Professor of Epidemiology

Trinity College Dublin School of Medicine

IRELAND

View details

Francisco Lopez-Jimenez

UNITED STATES

View details

Emanuele Di Angelantonio

University of Cambridge

UNITED KINGDOM

View details

Deirdre McGillicuddy

Dublin City University

IRELAND

View details

Sean Wharton

CANADA

View details

Royce P Vincent

Adjunct Senior Lecturer

King’s College London

UNITED KINGDOM

View details

Antonio E. Pontiroli

Università degli Studi di Torino

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Carel Le Roux

Research Interests

Explore related searches

Contact this professor

Articles (20)

“Treated as second class citizens” - the lived experience of obesity-related stigma: an IMI2 SOPHIA study

Semaglutide and blood pressure: an individual patient data meta-analysis

What influences patient decisions when selecting an obesity treatment?

“What would be left of me?” Patient perspectives on the risks of obesity treatment: An innovative health initiative stratification of obesity phenotypes to optimise future obesity therapy (IMI2 SOPHIA) qualitative study

Liver fibrosis and liver stiffness in patients with obesity and type 1 diabetes

Patient perceptions of success in obesity treatment: An IMI2 SOPHIA study

Real world use of tirzepatide in the treatment of type 2 diabetes in an Arab population

Obesity as a disease: a pressing need for alignment

Factors that determine patients considering medication for the disease of obesity: an IMI2 SOPHIA study

Hypothalamic control of body fat mass by food intake: The key to understanding why obesity should be treated as a disease

The efficacy of GLP‐1RAs for the management of postprandial hypoglycemia following bariatric surgery: a systematic review

Recent advances in the treatment of patients with obesity and chronic kidney disease

Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison

Weight loss to disrupt type 2 diabetes

Glucagon‐like peptide‐1 agonists combined with sodium‐glucose cotransporter‐2 inhibitors reduce weight in type 1 diabetes

Effect of Prolonged and Substantial Weight Loss on Incident Atrial Fibrillation: A Systematic Review and Meta-Analysis

Tirzepatide for the treatment of obesity: Rationale and design of the SURMOUNT clinical development program

Obesity and cardiovascular disease: mechanistic insights and management strategies. A joint position paper by the World Heart Federation and World Obesity Federation

The Concept of Healthy Behaviours in Obesity May Have Unintended Consequences

Upper gut heat shock proteins HSP70 and GRP78 promote insulin resistance, hyperglycemia, and non-alcoholic steatohepatitis

Collaborators (13)

Werd Al-Najim

ALEX MIRAS

Gary A Wittert

John Wilding

John McEvoy

Georgios K. Dimitriadis

Lina Zgaga

Francisco Lopez-Jimenez

Emanuele Di Angelantonio

Deirdre McGillicuddy

Sean Wharton

Royce P Vincent

Antonio E. Pontiroli

Make your next move.